Decentralized Trials Are Better Understood, but 5 Misconceptions Persist
Decentralized clinical trials became better understood after sponsors and CROs turned to them to rescue studies during the pandemic, but several misconceptions persist that are standing in the way of wider adoption of DCTs and the value they bring, including providing a more diverse range of participants access to potentially life-saving drugs.
This whitepaper lists five common concerns about DCTs and how a leading provider of mobile research services, PCM Trials, addresses them.
PCM Trials, an independent company headquartered in Denver, Colorado with European operations based out of the UK, brings clinical research to patients wherever and whenever it is most convenient for them. PCM Trials directly recruits, trains, certifies, and manages Certified Mobile Research Nurses (CMRNs) to ensure that each visit meets the highest standards for data quality and patient experience. For more information, visit pcmtrials.com.